Frontline Treatment For Renal Cell Carcinoma - Eric Jonasch

Frontline Treatment For Renal Cell Carcinoma - Eric Jonasch

Targeted Therapies For The Treatment Of Kidney Cancer, Eric Jonasch, MD

Frontline Treatment Approaches in Advanced RCC

#KCRS19: Eric Jonasch, M.D.

Frontline Management of Renal Cell Carcinoma

Frontline Treatment Options for Stage 4 RCC

What is the best front line treatment for metastatic clear cell RCC in 2018?

Eric Jonasch, MD, on integrating immunotherapies into renal cell carcinoma treatment algorithms

Choosing Frontline Therapy for Metastatic Kidney Cancer

What Are The Next Therapies On The Horizon For The Treatment Of Kidney Cancer? Eric Jonasch, MD

Dr. Jonasch on Single-Agent Pembrolizumab in Non-Clear Cell RCC

Comparison of Frontline Renal Cell Carcinoma Treatment Options

GU Oncology Now

Dr. Jonasch on the CABOSUN Trial in RCC

10.19.20 Urology COViD Didactics - Treating Metastatic Renal Cell Carcinoma

Urology Residents

Systemic targeted therapy for metastatic renal cell carcinoma in 2012 Eric Jonasch, M.D

Frontline Sunitinib Compared to Everolimus in Metastatic Renal Cell Carcinoma

Review of the Data of Frontline Treatment for Non-Clear Cell Kidney Cancer

GU Oncology Now

Dr. Jonasch on First- and Second-line Options for Patients With RCC

Introduction and Frontline Treatment of Renal Cell Carcinoma

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023

Touch Medical Media Services